SAN FRANSISCO, CA – Five additional studies of note are among those that will be presented at the 2013 Breast Cancer Symposium, taking place September 7-9, 2013 at the San Francisco Marriott Marquis in San Francisco, California. Two studies examine cognitive function in women who undergo treatment for early-stage breast cancer; a third evaluates impact of tumor genotyping on clinical trial enrollment; and the final two evaluate the outcomes of different treatment approaches.
Saturday, September 7 Presentations
Abstract #48:
Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy (NCT) and analysis of survival outcome.
General Poster Session A
Saturday, September 7, 2013, 11:30 AM – 1:00 PM PST
Saturday, September 7, 2013, 4:30 PM – 6:00 PM PST
Golden Gate Hall
Napa Parinyanitikul, MD
The University of Texas MD Anderson Cancer Center
Houston, TX
Abstract # 55:
Ten-year outcomes of accelerated partial breast irradiation compared with whole breast irradiation: A matched-pair analysis.
Poster Discussion A
Saturday, September 7, 2013, 4:00 PM – 4:20 PM PST
Yerba Buena Ballroom, Salon 8
Jessica Wobb, MD
Oakland University William Beaumont School of
Medicine, Beaumont Cancer Institute
Royal Oak, MI
Sunday, September 8 Presentations
Abstract # 105:
Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (BC): Relationship between perceived and measurable cognitive deficits.
Poster Discussion B
Sunday, September 8, 2013, 3:00 PM – 3:20 PM PST
Yerba Buena Ballroom, Salon 8
Lara Heflin, PhD
New Mexico Highlands University
Las Vegas, NM
Abstract # 104:
Prospective study of cognitive function (cog fcn) in women with early-stage breast cancer (ESBC): Predictors of cognitive decline.
Poster Discussion B
Sunday, September 8, 2013, 3:00 PM – 3:20 PM PST
Yerba Buena Ballroom, Salon 8
Hope S. Rugo, MD
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Abstract # 145:
Impact of routine tumor genotyping on enrollment in targeted therapy trials for metastatic breast cancer (MBC): 4-year review.
Poster Discussion B
Sunday, September 8, 2013, 4:00 PM – 4:20 PM PST
Yerba Buena Ballroom, Salon 8
Aditya Bardia, MD
Massachusetts General Hospital,
Harvard Medical School
Boston, MA
2013 Breast Cancer Symposium News Planning Team
Dennis R. Holmes, M.D., FACS, American Society of Breast Disease (ASBD); Deanna J. Attai, MD, FACS, The American Society of Breast Surgeons; Steven O'Day, MD, American Society of Clinical Oncology (ASCO); Bruce G. Haffty, MD, FASTRO, American Society for Radiation Oncology (ASTRO); Anees B. Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C), The Society of Surgical Oncology (SSO), William R. Poller, MD, FACR, National Consortium of Breast Centers (NCBC).
ATTRIBUTION TO THE 2013 BREAST CANCER SYMPOSIUM IS REQUESTED IN ALL NEWS COVERAGE.